Back to results
US 9,750,717 B2Granted
Inhibitors of CD40-TRAF6 interaction
AssigneesLudwig-Maximilians-Universitat Munchen, Maastricht University
InventorsEsther Lutgens, Christian Weber, Gerry Nicolaes
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
Claims7
A pharmaceutical composition comprising a compound having a formula selected from the group consisting of
- or a pharmaceutically acceptable salt thereof
- and at least one pharmaceutically acceptable carrier, diluent and/or excipient.
Dependencies are inferred from the claim text.